Panel Recommends PMAs For Cranial Electrotherapy Stimulators
This article was originally published in The Gray Sheet
Executive Summary
FDA’s Neurological Devices panel recommends that pre-amendment cranial electrotherapy stimulator devices should remain in class III, with PMA requirements, due to a lack of efficacy data.